Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 235 | $31,547,064 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 13 | 14.85 | 193 | I |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 63 | 9.4532 | 596 | D |
03 Oct 2022 19:32 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Sep 2022 | Sale | 64 | 11.53 | 738 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 63 | 13.7541 | 867 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 12.3559 | 1,569 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 14.0601 | 1,786 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 236 | 10.8698 | 2,565 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 500 | 7.3789 | 3,689 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 500 | 7.9041 | 3,952 | I |
21 Feb 2024 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Feb 2024 | Sale | 309 | 13.0432 | 4,030 | D |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 500 | 9.2082 | 4,604 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 500 | 9.2648 | 4,632 | I |
02 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 01 Feb 2023 | Purchase | 600 | 7.97 | 4,782 | I |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 1,000 | 4.9151 | 4,915 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 500 | 10.1104 | 5,055 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 1,000 | 5.137 | 5,137 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 500 | 11.6421 | 5,821 | I |
01 Mar 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 28 Feb 2023 | Purchase | 815 | 7.97 | 6,496 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 561 | 11.8245 | 6,634 | I |
25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 610 | 11.3361 | 6,915 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 500 | 14.048 | 7,024 | D |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 1,000 | 7.3822 | 7,382 | I |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 1,000 | 7.3907 | 7,391 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 550 | 14.0291 | 7,716 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9059 | 7,906 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9086 | 7,909 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 1,000 | 8.0867 | 8,087 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 1,000 | 8.8363 | 8,836 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 10.8206 | 9,198 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 1,000 | 9.2017 | 9,202 | I |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 1,000 | 9.2075 | 9,208 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 1,000 | 9.2773 | 9,277 | I |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 1,000 | 9.2773 | 9,277 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 1,000 | 9.4939 | 9,494 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 1,000 | 10.0984 | 10,098 | I |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 1,000 | 10.0993 | 10,099 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 12.4076 | 10,546 | I |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 1,000 | 11.5621 | 11,562 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 1,000 | 11.6414 | 11,641 | I |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 1,000 | 11.6428 | 11,643 | I |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 1,067 | 10.9841 | 11,720 | D |
11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 962 | 14.0282 | 13,495 | I |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Feb 2023 | Sale | 1,768 | 8.42 | 14,887 | D |
30 Oct 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 26 Oct 2023 | Sale | 3,000 | 5.6283 | 16,885 | D |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 4,000 | 4.9058 | 19,623 | I |
17 Nov 2023 17:53 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 16 Nov 2023 | Sale | 3,000 | 6.7599 | 20,280 | D |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 4,000 | 5.1411 | 20,564 | I |
03 Jul 2023 15:21 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Jun 2023 | Sale | 3,000 | 7.49 | 22,470 | D |
29 Apr 2024 18:41 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 25 Apr 2024 | Sale | 3,000 | 7.6735 | 23,020 | D |
02 Oct 2023 18:19 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 28 Sep 2023 | Sale | 3,000 | 7.7198 | 23,159 | D |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 2,937 | 8.639 | 25,373 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 2,173 | 11.8005 | 25,642 | I |
02 Jun 2023 18:05 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 31 May 2023 | Sale | 3,000 | 8.6294 | 25,888 | D |
03 Jun 2024 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 30 May 2024 | Sale | 3,000 | 8.775 | 26,325 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 1,991 | 14.3626 | 28,596 | D |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 4,000 | 8.0904 | 32,362 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 4,000 | 8.8337 | 35,335 | I |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 4,700 | 7.6168 | 35,799 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,423 | 10.8658 | 37,194 | D |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 4,000 | 9.5073 | 38,029 | I |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 3,272 | 11.7468 | 38,436 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,270 | 12.3873 | 40,506 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 3,195 | 13.1845 | 42,124 | D |
28 Jun 2024 17:14 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 27 Jun 2024 | Sale | 6,000 | 7.215 | 43,290 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 3,157 | 14.0821 | 44,457 | D |
17 May 2023 18:22 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 May 2023 | Sale | 8,885 | 5.0918 | 45,241 | D |
03 Sep 2024 16:48 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 29 Aug 2024 | Sale | 6,000 | 7.5627 | 45,376 | D |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 4,000 | 11.5648 | 46,259 | I |
02 Nov 2023 19:02 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 31 Oct 2023 | Sale | 8,885 | 5.2745 | 46,864 | D |
28 Jul 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Jul 2023 | Sale | 3,627 | 13.1155 | 47,570 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,430 | 10.8382 | 48,013 | I |
29 Jul 2024 18:16 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 25 Jul 2024 | Sale | 6,000 | 8.1349 | 48,809 | D |
15 Feb 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 14 Feb 2023 | Purchase | 6,300 | 7.946 | 50,060 | I |
20 Apr 2023 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 18 Apr 2023 | Sale | 8,885 | 5.9347 | 52,730 | D |
18 Oct 2022 17:08 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 14 Oct 2022 | Sale | 5,000 | 10.6259 | 53,130 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 4,060 | 13.3631 | 54,254 | D |
18 Oct 2022 17:08 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 14 Oct 2022 | Sale | 5,000 | 11.21 | 56,050 | D |
16 Nov 2023 18:55 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 14 Nov 2023 | Sale | 8,885 | 6.3197 | 56,151 | D |
06 Apr 2023 17:38 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 04 Apr 2023 | Sale | 8,885 | 6.5269 | 57,992 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,693 | 12.4131 | 58,255 | I |
19 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 17 Oct 2023 | Sale | 8,885 | 6.5822 | 58,483 | D |
17 Nov 2022 18:47 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2022 | Sale | 4,941 | 11.9153 | 58,873 | D |
13 Jul 2023 16:54 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 11 Jul 2023 | Sale | 8,885 | 6.8873 | 61,194 | D |
28 Jul 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Jul 2023 | Sale | 4,373 | 14.0461 | 61,424 | D |
30 Dec 2022 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Dec 2022 | Sale | 8,000 | 7.6958 | 61,566 | D |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Feb 2023 | Sale | 7,486 | 8.33 | 62,358 | D |
27 Feb 2023 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 23 Feb 2023 | Sale | 8,000 | 7.8175 | 62,540 | D |
27 Jan 2023 16:27 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 26 Jan 2023 | Purchase | 7,886 | 7.9896 | 63,006 | I |
17 Nov 2022 18:47 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2022 | Sale | 5,059 | 12.7 | 64,249 | D |
29 Dec 2022 17:39 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 27 Dec 2022 | Sale | 8,885 | 7.2451 | 64,373 | D |
27 Jan 2023 17:03 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 26 Jan 2023 | Sale | 8,000 | 8.0684 | 64,547 | D |
05 Oct 2023 18:25 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 03 Oct 2023 | Sale | 8,885 | 7.2907 | 64,778 | D |
29 Jun 2023 17:57 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 27 Jun 2023 | Sale | 8,885 | 7.3876 | 65,639 | D |
23 Mar 2023 17:07 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 21 Mar 2023 | Sale | 8,885 | 7.3994 | 65,744 | D |
12 Jan 2023 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 10 Jan 2023 | Sale | 8,885 | 7.6852 | 68,283 | D |
23 Feb 2023 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 21 Feb 2023 | Sale | 8,885 | 7.733 | 68,708 | D |
05 Sep 2024 17:25 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 03 Sep 2024 | Sale | 11,447 | 6.2652 | 71,718 | D |
09 Mar 2023 17:36 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 07 Mar 2023 | Sale | 8,885 | 8.3274 | 73,989 | D |
21 Sep 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 19 Sep 2023 | Sale | 8,885 | 8.3599 | 74,278 | D |
30 Nov 2023 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 28 Nov 2023 | Sale | 11,447 | 6.7195 | 76,918 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)